Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
In the News
In the News
,
Leukemia
,
Oncology
November 4, 2019 — Oncology News & Updates
Read More
FDA Approvals
,
In the News
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer
,
FDA Approvals
,
In the News
,
Multiple Myeloma
,
Pediatric Cancer
,
Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
In the News
FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments
Read More
FDA Approvals
,
Multiple Myeloma
,
In the News
,
Oncology
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
FDA Approvals
,
In the News
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Read More
FDA Approvals
,
In the News
First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL
Read More
Breast Cancer
,
FDA Approvals
,
In the News
,
Oncology
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Read More
FDA Approvals
,
In the News
Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation
Read More
FDA Approvals
,
In the News
FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma
Read More
1
2
3
4
5
Page 2 of 7
Results 11 - 20 of 62